metricas
covid
Annals of Hepatology IMPROVEMENT OF CARDIOVASCULAR RISK ASSESSMENT ON A COHORT OF PATIENTS WITH METAB...
Journal Information
Vol. 30. Issue S2.
Abstracts of the 2025 Annual Meeting of the ALEH
(September 2025)
Vol. 30. Issue S2.
Abstracts of the 2025 Annual Meeting of the ALEH
(September 2025)
#17
Full text access
IMPROVEMENT OF CARDIOVASCULAR RISK ASSESSMENT ON A COHORT OF PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
Visits
180
Pedro Miguel Mattos Nogueira1, Carlos Eduardo Cruz Marques2, Breno Corrêa Vieira3, Ana Carolina Cardoso4, Natalia Wajbrot4, Claudia Equi4, Nathalie Carvalho Leite4, Glaucia Moraes de Oliveira5, Cristiane Villela-Nogueira5
1 Faculdade de Medicina Souza Marques e Programa de Pós-Graduação em Cardiologia da Universidade Federal do Rio de Janeiro, Brasil.
2 Programa de Pós Graduação em Clínica Médica. Faculdade de Medicina. Universidade Federal do Rio de Janeiro, Brasil.
3 Programa de Iniciação Científica. FAPERJ e Faculdade de Medicina. Universidade Federal do Rio de Janeiro, Brasil.
4 Serviço de Hepatologia. Hospital Universitário Clementino Fraga Filho. Universidade Federal do Rio de Janeiro, Brasil.
5 Faculdade de Medicina. Universidade Federal do Rio de Janeiro, Brasil.
This item has received
Article information
Abstract
Full Text
Download PDF
Statistics
Special issue
This article is part of special issue:
Vol. 30. Issue S2

Abstracts of the 2025 Annual Meeting of the ALEH

More info
Introduction and Objectives

Pulse Wave Velocity (PWV) and ultrasound analysis of the carotid and femoral arteries (CA/FA) may offer a more accurate estimation of the cardiovascular risk (CVR) than traditional scores beyond the Coronary Calcium Score. The aim was to evaluate the impact of PWV and Doppler examinations of the CA/FA as modifiers of CVR in MASLD-patients in whom traditional scores were calculated.

Patients and Methods

This was a sectional study in MASLD-outpatients without clinical atherosclerotic disease. The AHA/ACC, Framingham and PREVENT scores were calculated, with a value ≥ 20% considered high-risk. PWV index (patient-PWV/median PWV of the National CVR standard) was assessed (Arteris® AOP), and if ≥ 1 was considered as high-risk. CA/FA Doppler (Affiniti-70, Philips, USA) identified atherosclerotic plaques. The prevalence of high-risk patients was first calculated according to each score and reassessed after PWV and Doppler of CA/FA.

Results

One hundred fifty-three patients were evaluated between Oct-2023 and Mar-2025 (78% women, 60.2 ± 9.4 yrs., 68% obese, 79% SAH, 67% T2DM, 77% dyslipidemia). Regarding overall scores, 32% of patients were classified as high risk (Prevent 15%, AHA/ACC 18%, Framingham 26%). Notably, a high PWV-index was observed in 33%, and 76% had atherosclerotic plaques, characterizing established atherosclerotic disease. The risk reclassification by the PWV-index ocurred in 21%,25%, and 28%, and by the Doppler 53%,60%, and 62%, respectively, for the Framingham, AHA/ACC, and Prevent scores.

Conclusions

Patients with MASLD have a high prevalence of subclinical atherosclerosis. Traditional scores underestimated CVR, highlighting the need for additional methods for better risk stratification.

Full Text

Conflict of interest: None

Download PDF
Article options
Tools